Cambridge, UK, 6th December 2017 / Domainex Ltd, a privately-owned drug discovery services company, is pleased to announce that Chris Brown has been appointed Chief Financial Officer with immediate effect.
6th December 2017
12th September 2017
Cambridge, UK and Stevenage, UK – 12 September 2017 - Domainex and Auspherix have announced new data from their collaboration to develop novel candidate drugs to tackle the growing thre
14th June 2017
Cambridge, UK, 14 June 2017/ Domainex Ltd.
17th May 2017
Domainex signs multi-year agreement with Dotmatics – a leading provider of scientific informatics – to streamline its integrated drug discovery services
30th March 2017
Domainex, a drug discovery services company, is pleased to announce that Dr Timo Veromaa has been appointed Executive Chairman with immediate effect.
7th March 2017
Domainex launched its fragment screening service, FragmentBuilder, and is the first CRO in the UK to offer MicroScale Thermophoresis (MST) as part of drug discovery services.